By Raj Grover
As demand surges in foreign markets, Canada has a chance to cement its spot as Europe’s top medical cannabis partner.
Prime Minister has set an ambitious goal: to double Canada’s non-U.S. exports within the next decade, generating an estimated $300 billion in additional trade.
The medical cannabis industry fits that profile perfectly, combining global demand with proven domestic expertise and strong regulatory credibility.
Canada must focus on sectors that combine global demand with proven domestic expertise and strong regulatory credibility.
Author's summary: Canada aims to double non-U.S. exports.